Free Trial
NASDAQ:COCH

Envoy Medical (COCH) Stock Price, News & Analysis

Envoy Medical logo
$1.36 -0.02 (-1.09%)
As of 04/4/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Envoy Medical Stock (NASDAQ:COCH)

Key Stats

Today's Range
$1.22
$1.44
50-Day Range
$1.30
$1.67
52-Week Range
$1.21
$7.20
Volume
45,414 shs
Average Volume
86,677 shs
Market Capitalization
$27.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00
Consensus Rating
Buy

Company Overview

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

Remove Ads

Envoy Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

COCH MarketRank™: 

Envoy Medical scored higher than 38% of companies evaluated by MarketBeat, and ranked 691st out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Envoy Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Envoy Medical has received no research coverage in the past 90 days.

  • Read more about Envoy Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Envoy Medical are expected to decrease in the coming year, from ($1.21) to ($1.23) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Envoy Medical is -0.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Envoy Medical is -0.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Envoy Medical's valuation and earnings.
  • Percentage of Shares Shorted

    1.00% of the float of Envoy Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Envoy Medical has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Envoy Medical has recently decreased by 4.11%, indicating that investor sentiment is improving.
  • Dividend Yield

    Envoy Medical does not currently pay a dividend.

  • Dividend Growth

    Envoy Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.00% of the float of Envoy Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Envoy Medical has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Envoy Medical has recently decreased by 4.11%, indicating that investor sentiment is improving.
  • News Sentiment

    Envoy Medical has a news sentiment score of -1.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Envoy Medical this week, compared to 0 articles on an average week.
  • MarketBeat Follows

    2 people have added Envoy Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Envoy Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    60.50% of the stock of Envoy Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 8.59% of the stock of Envoy Medical is held by institutions.

  • Read more about Envoy Medical's insider trading history.
Receive COCH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Envoy Medical and its competitors with MarketBeat's FREE daily newsletter.

COCH Stock News Headlines

Envoy Medical (COCH) to Release Quarterly Earnings on Monday
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
Envoy Medical announces four new patents
Lake Street Sticks to Their Buy Rating for Envoy Medical (COCH)
Envoy Medical reports Q3 EPS (37c) vs. 13c last year.
See More Headlines

COCH Stock Analysis - Frequently Asked Questions

Envoy Medical's stock was trading at $1.43 at the start of the year. Since then, COCH shares have decreased by 3.8% and is now trading at $1.3750.
View the best growth stocks for 2025 here
.

Envoy Medical, Inc. (NASDAQ:COCH) announced its quarterly earnings results on Friday, March, 28th. The company reported ($0.45) EPS for the quarter, missing the consensus estimate of ($0.33) by $0.12. The firm had revenue of $0.04 million for the quarter, compared to the consensus estimate of $0.07 million.

Shares of COCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Envoy Medical investors own include Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Tesla (TSLA), XPeng (XPEV), AbCellera Biologics (ABCL), AutoZone (AZO) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
3/28/2025
Today
4/04/2025
Next Earnings (Estimated)
4/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:COCH
Fax
N/A
Employees
34
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$9.00
High Stock Price Target
$9.00
Low Stock Price Target
$9.00
Potential Upside/Downside
+554.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-29,910,000.00
Net Margins
-7,607.55%
Pretax Margin
-7,607.55%

Debt

Sales & Book Value

Annual Sales
$225,000.00
Price / Cash Flow
N/A
Book Value
($0.09) per share
Price / Book
-15.28

Miscellaneous

Free Float
7,997,000
Market Cap
$27.84 million
Optionable
Not Optionable
Beta
2.35
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:COCH) was last updated on 4/5/2025 by MarketBeat.com Staff
From Our Partners